Hong Kong · Delayed Price · Currency is HKD BeOne Medicines AG Statistics
Total Valuation
HKG:6160 has a market cap or net worth of HKD 260.35 billion. The enterprise value is 238.88 billion.
| Market Cap | 260.35B |
| Enterprise Value | 238.88B |
Important Dates
The next confirmed earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.33B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.10% |
| Shares Change (QoQ) | +1.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 78.21M |
Valuation Ratios
The trailing PE ratio is 64.73 and the forward PE ratio is 44.31.
| PE Ratio | 64.73 |
| Forward PE | 44.31 |
| PS Ratio | 5.79 |
| PB Ratio | 6.98 |
| P/TBV Ratio | 7.07 |
| P/FCF Ratio | 29.79 |
| P/OCF Ratio | 25.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.68, with an EV/FCF ratio of 27.34.
| EV / Earnings | 59.39 |
| EV / Sales | 5.31 |
| EV / EBITDA | 35.68 |
| EV / EBIT | 44.52 |
| EV / FCF | 27.34 |
Financial Position
The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.43.
| Current Ratio | 3.64 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 2.40 |
| Debt / FCF | 1.84 |
| Interest Coverage | 8.15 |
Financial Efficiency
Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 37.33%.
| Return on Equity (ROE) | 12.42% |
| Return on Assets (ROA) | 5.96% |
| Return on Invested Capital (ROIC) | 37.33% |
| Return on Capital Employed (ROCE) | 10.17% |
| Weighted Average Cost of Capital (WACC) | 6.75% |
| Revenue Per Employee | 3.75M |
| Profits Per Employee | 335,175 |
| Employee Count | 12,000 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.14 |
Taxes
In the past 12 months, HKG:6160 has paid 1.11 billion in taxes.
| Income Tax | 1.11B |
| Effective Tax Rate | 21.70% |
Stock Price Statistics
The stock price has increased by +22.01% in the last 52 weeks. The beta is 0.49, so HKG:6160's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +22.01% |
| 50-Day Moving Average | 174.38 |
| 200-Day Moving Average | 189.02 |
| Relative Strength Index (RSI) | 59.94 |
| Average Volume (20 Days) | 5,052,750 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, HKG:6160 had revenue of HKD 45.00 billion and earned 4.02 billion in profits. Earnings per share was 34.53.
| Revenue | 45.00B |
| Gross Profit | 39.74B |
| Operating Income | 5.38B |
| Pretax Income | 5.14B |
| Net Income | 4.02B |
| EBITDA | 6.47B |
| EBIT | 5.38B |
| Earnings Per Share (EPS) | 34.53 |
Balance Sheet
The company has 37.57 billion in cash and 16.10 billion in debt, with a net cash position of 21.47 billion.
| Cash & Cash Equivalents | 37.57B |
| Total Debt | 16.10B |
| Net Cash | 21.47B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 37.32B |
| Book Value Per Share | 335.89 |
| Working Capital | 37.55B |
Cash Flow
In the last 12 months, operating cash flow was 10.07 billion and capital expenditures -1.33 billion, giving a free cash flow of 8.74 billion.
| Operating Cash Flow | 10.07B |
| Capital Expenditures | -1.33B |
| Depreciation & Amortization | 7.45B |
| Net Borrowing | 8.47B |
| Free Cash Flow | 8.74B |
| FCF Per Share | n/a |
Margins
Gross margin is 88.31%, with operating and profit margins of 11.95% and 8.94%.
| Gross Margin | 88.31% |
| Operating Margin | 11.95% |
| Pretax Margin | 11.42% |
| Profit Margin | 8.94% |
| EBITDA Margin | 14.38% |
| EBIT Margin | 11.95% |
| FCF Margin | 19.42% |
Dividends & Yields
HKG:6160 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.10% |
| Shareholder Yield | -10.10% |
| Earnings Yield | 1.54% |
| FCF Yield | 3.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:6160 is 254.01, which is 38.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 254.01 |
| Price Target Difference | 38.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 16.15% |
| EPS Growth Forecast (3Y) | 79.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:6160 has an Altman Z-Score of 5.51 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.51 |
| Piotroski F-Score | 7 |